Natco Pharma's partner Mylan Inc files ANDA for generic Copaxone

According to IMS health, Copaxone 40 mg/mL had US sales of nearly USD 411.5 million for the 12 months ending June 30, 2014, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news